Trials and Translation Bringing stem cell therapies to Ontario Stem cells were first identified in Ontario in 1961. Today, Ontario remains a world leader in stem cell and regenerative medicine research. The Ontario Institute for Regenerative Medicine is helping push even further by supporting the scientists, clinicians and technologies that will make today’s regenerative medicine advances tomorrow’s reality. Phase 1 15–30 patients Animal and/or laboratory studies About 4-1/2 years Phase II Fewer than 100 patients Phase III 100s to 1000s of patients About 8-1/2 years Phase IV After approval Health Canada approval About 1-1/2 years How science becomes medicine Before a new discovery becomes a treatment or cure, it goes through a rigourous process to ensure that it’s both safe and effective. Early tests often involve animals before moving on to humans. Human clinical trials have four phases and the therapy must pass each phase before getting approval for regular clinical use. Cell therapy clinical trials in Ontario in 2015 Each year, thousands of Ontario patients take part in a clinical trial to help move science forward. These eight trials represent some of the current and planned trials involving stem cells and are areas of active interest for OIRM. For information on these trials and their sponsors, visit clinicaltrials.gov. BRAIN AND/OR NERVES HEART 2 Phase II trial using mesenchymal stem cell for patients with Multiple Sclerosis: 40 patients; Ottawa* 2 Phase II trial using genetically modified stem cells for cardiac patients following a heart attack: 100 patients; Ottawa and Toronto* Phase III trial using a diabetes drug to stimulate brain repair and recovery in children treated with radiation for malignant brain tumours: 30 patients; Toronto* 2015 Phase II trial injecting mesenchymal stem cells into heart tissue of patients with advanced heart failure who have been treated with left ventricular assist device: 120 patients; Toronto* 8 trials 11 partners BLOOD 1 Phase I trial for safety of immune cells to treat refractory blood cancer relapse after bone marrow transplantation: 15 patients; Toronto* 3 Ontario cities 647+ patients SPINE 1 Phase I/II trial testing effect of transplantation of human stem cells in patients with cervical spinal cord trauma: undetermined number of patients; Toronto* Billions of stem cells KNEE DIGESTIVE SYSTEM 1 Phase I-II trial using stem cells for the treatment of mid to late stage knee osteoarthritis; 12 patients, Toronto* 1 Phase III trial using mesenchymal stem cells to induce remission of Crohn’s Disease: 330 patients; London and Toronto *OIRM researchers leading trial Your imagination. OIRM’s expertise. Our future. www.oirm.ca Funding provided in part by the Government of Ontario.
© Copyright 2024